⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3669070 | 1.00 | — | — | |
| SCHEMBL27839470 | 0.76 | TET2 (0.44) | — | |
| SCHEMBL3664299 | 0.76 | TET2 (0.44) | — | |
| SCHEMBL3665923 | 0.75 | ADH1B (0.44) | — | |
| SCHEMBL7579345 | 0.74 | OR51E2 (0.46) | — | |
| SCHEMBL3985974 | 0.73 | — | — | |
| SCHEMBL11307094 | 0.73 | — | — | |
| SCHEMBL25660500 | 0.73 | — | — | |
| SCHEMBL14121139 | 0.73 | ADH1B (0.43) | — | |
| SCHEMBL8897053 | 0.73 | ADH1B (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0547031-B1 | N-protected-(S)-isoserine compounds | SCHERING CORP (US) | 1997-04-23 | — | — | EP | claimed |
| US-5442047-A | Process for preparing isepamicin | SCHERING CORPORATION (US) | 1995-08-15 | — | — | US | claimed |
| EP-0405820-B1 | Improved process for preparing isepamicin | SCHERING CORP (US) | 1994-04-13 | — | — | EP | claimed |
| EP-0547031-A1 | N-protected-(S)-isoserine compounds | SCHERING CORPORATION (US) | 1993-06-16 | — | — | EP | claimed |
| EP-0478707-A1 | IMPROVED PROCESS FOR PREPARING ISEPAMICIN | SCHERING CORPORATION (US) | 1992-04-08 | — | — | EP | claimed |
| EP-0405820-A2 | Improved process for preparing isepamicin | SCHERING CORPORATION (US) | 1991-01-02 | — | — | EP | claimed |
| WO-1990015810-A2 | IMPROVED PROCESS FOR PREPARING ISEPAMICIN | SCHERING CORPORATION (US) | 1990-12-27 | — | — | WO | claimed |
| EP-0547031-B1 | N-protected-(S)-isoserine compounds | SCHERING CORP (US) | 1997-04-23 | — | — | EP | disclosed |
| US-5539121-A | 2-formylmercaptobenzothiazole | SCHERING CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
| US-5442047-A | Process for preparing isepamicin | SCHERING CORPORATION (US) | 1995-08-15 | — | — | US | disclosed |
| EP-0405820-B1 | Improved process for preparing isepamicin | SCHERING CORP (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0547031-A1 | N-protected-(S)-isoserine compounds | SCHERING CORPORATION (US) | 1993-06-16 | — | — | EP | disclosed |
| EP-0547031-A1 | N-protected-(S)-isoserine compounds | SCHERING CORPORATION (US) | 1993-06-16 | — | — | EP | disclosed |
| EP-0478707-A1 | IMPROVED PROCESS FOR PREPARING ISEPAMICIN | SCHERING CORPORATION (US) | 1992-04-08 | — | — | EP | disclosed |
| EP-0405820-A2 | Improved process for preparing isepamicin | SCHERING CORPORATION (US) | 1991-01-02 | — | — | EP | disclosed |
| WO-1990015810-A2 | IMPROVED PROCESS FOR PREPARING ISEPAMICIN | SCHERING CORPORATION (US) | 1990-12-27 | — | — | WO | disclosed |